• Search
  • Basket
    You have no items in your basket
Martijn Cox

Martijn Cox

Chief Technology Officer - Xeltis BV, the Netherlands

Chief Technology Officer, Xeltis BV, Netherlands

Martijn Cox is Co-Founder and CTO of Xeltis, a clinical-stage medical device company developing the first ever blood vessels and heart valves enabling cardiovascular restoration through a therapeutic approach called Endogenous Tissue Restoration (ETR). The porous structure of Xeltis’ restorative cardiovascular implants enables cardiovascular restoration by harnessing the body’s natural healing process to pervade it with new healthy tissue once implanted. As a new healthy blood vessel or heart valve made of patient’s own tissue forms around the structure of the implant and takes over functionality, the original implant gets absorbed in the body. Xeltis’ cardiovascular implants are made of bioabsorbable supramolecular polymers. To date, 28 children have received a Xeltis cardiovascular implant, during several small First-In-Human studies. Xeltis is currently working to bring first applications for adult patients to clinical stage.